Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DICE

DICE Therapeutics (DICE) Stock Price, News & Analysis

DICE Therapeutics logo

About DICE Therapeutics Stock (NASDAQ:DICE)

Advanced Chart

Key Stats

Today's Range
$47.55
$47.55
50-Day Range
$46.62
$47.55
52-Week Range
$15.08
$47.90
Volume
N/A
Average Volume
1.03 million shs
Market Capitalization
$2.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DICE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DICE Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DICE Stock News Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation.
Buy, Sell, Or Hold LLY Stock At $850?
See More Headlines

DICE Stock Analysis - Frequently Asked Questions

DICE Therapeutics, Inc. (NASDAQ:DICE) announced its quarterly earnings data on Friday, November, 12th. The company reported ($2.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $1.77.

DICE Therapeutics (DICE) raised $160 million in an initial public offering on Wednesday, September 15th 2021. The company issued 10,000,000 shares at a price of $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that DICE Therapeutics investors own include Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX), Honeywell International (HON), HubSpot (HUBS), Walt Disney (DIS) and Bank of America (BAC).

Company Calendar

Last Earnings
11/12/2021
Today
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:DICE
CIK
1645569
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.89 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-22.01%
Return on Assets
-20.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
25.88
Quick Ratio
32.44

Sales & Book Value

Annual Sales
$1.13 million
Price / Sales
2,008.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.86 per share
Price / Book
4.38

Miscellaneous

Outstanding Shares
47,731,000
Free Float
45,392,000
Market Cap
$2.27 billion
Optionable
Not Optionable
Beta
1.03
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DICE) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners